StockTipsArenaBeta

BUY Jubilant Pharmova Limited — Rakesh Bansal

BUYJubilant Pharmova Limited
Jubilant Pharmova share price target & all analyst calls

byRakesh BansalHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via CNBC Awaaz.

Entry₹1,050.85Inferred
Target₹1,075
Total upside +2.30% (call closed)
Stop loss₹1,037-1.32% risk
Exit₹1,07522 Sept 2026, 2:00 pm
Target hit+2.30%0.00%upside left
Follow Rakesh Bansal for new calls(31% target hit, 269 closed calls)Get alertsWatch JUBLPHARMA for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 4:38 pm IST
1 supporting1 neutral0 opposing
Supports the BUY call (1)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·21 Sept · yesterday

Neutral / worth noting (1)

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification

NewsCnbc-Tv18·11 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Pharmova

All analyst calls on Jubilant Pharmova

More from Rakesh Bansal

Every call and its outcome